True Interindividual Variability Exists in Postprandial Appetite Responses in Healthy Men But Is Not Moderated by the FTO Genotype.
FTO
PYY
appetite
ghrelin
hunger
individual variability
replicated crossover design
Journal
The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243
Informations de publication
Date de publication:
01 07 2019
01 07 2019
Historique:
received:
07
01
2019
revised:
05
02
2019
accepted:
11
03
2019
pubmed:
28
5
2019
medline:
9
4
2020
entrez:
28
5
2019
Statut:
ppublish
Résumé
After meal ingestion, a series of coordinated hormone responses occur concomitantly with changes in perceived appetite. It is not known whether interindividual variability in appetite exists in response to a meal. The aim of this study was to 1) assess the reproducibility of appetite responses to a meal; 2) quantify individual differences in responses; and 3) explore any moderating influence of the fat mass and obesity associated (FTO) gene. Using a replicated crossover design, 18 healthy men (mean ± SD age: 28.5 ± 9.8 y; BMI: 27.0 ± 5.0 kg/m2) recruited according to FTO genotype (9 AA, 9 TT) completed 2 identical control and 2 identical standardized meal conditions (5025 kJ) in randomized sequences. Perceived appetite and plasma acylated ghrelin, total peptide YY (PYY), insulin, and glucose concentrations were measured before and after interventions as primary outcomes. Interindividual differences were explored using Pearson's product-moment correlations between the first and second replicates of the control-adjusted meal response. Within-participant covariate-adjusted linear mixed models were used to quantify participant-by-condition and genotype-by-condition interactions. The meal suppressed acylated ghrelin and appetite perceptions [standardized effect size (ES): 0.18-4.26] and elevated total PYY, insulin, and glucose (ES: 1.96-21.60). For all variables, SD of change scores was greater in the meal than in the control conditions. Moderate-to-large positive correlations were observed between the 2 replicates of control-adjusted meal responses for all variables (r = 0.44-0.86, P ≤ 0.070). Participant-by-condition interactions were present for all variables (P ≤ 0.056). FTO genotype-by-condition interactions were nonsignificant (P ≥ 0.19) and treatment effect differences between genotype groups were small (ES ≤ 0.27) for all appetite parameters. Reproducibility of postprandial appetite responses is generally good. True interindividual variability is present beyond any random within-subject variation in healthy men but we detected no moderation by the FTO genotype. These findings highlight the importance of exploring individual differences in appetite for the prevention and treatment of obesity. This trial was registered at clinicaltrials.gov as NCT03771690.
Sections du résumé
BACKGROUND
After meal ingestion, a series of coordinated hormone responses occur concomitantly with changes in perceived appetite. It is not known whether interindividual variability in appetite exists in response to a meal.
OBJECTIVES
The aim of this study was to 1) assess the reproducibility of appetite responses to a meal; 2) quantify individual differences in responses; and 3) explore any moderating influence of the fat mass and obesity associated (FTO) gene.
METHODS
Using a replicated crossover design, 18 healthy men (mean ± SD age: 28.5 ± 9.8 y; BMI: 27.0 ± 5.0 kg/m2) recruited according to FTO genotype (9 AA, 9 TT) completed 2 identical control and 2 identical standardized meal conditions (5025 kJ) in randomized sequences. Perceived appetite and plasma acylated ghrelin, total peptide YY (PYY), insulin, and glucose concentrations were measured before and after interventions as primary outcomes. Interindividual differences were explored using Pearson's product-moment correlations between the first and second replicates of the control-adjusted meal response. Within-participant covariate-adjusted linear mixed models were used to quantify participant-by-condition and genotype-by-condition interactions.
RESULTS
The meal suppressed acylated ghrelin and appetite perceptions [standardized effect size (ES): 0.18-4.26] and elevated total PYY, insulin, and glucose (ES: 1.96-21.60). For all variables, SD of change scores was greater in the meal than in the control conditions. Moderate-to-large positive correlations were observed between the 2 replicates of control-adjusted meal responses for all variables (r = 0.44-0.86, P ≤ 0.070). Participant-by-condition interactions were present for all variables (P ≤ 0.056). FTO genotype-by-condition interactions were nonsignificant (P ≥ 0.19) and treatment effect differences between genotype groups were small (ES ≤ 0.27) for all appetite parameters.
CONCLUSIONS
Reproducibility of postprandial appetite responses is generally good. True interindividual variability is present beyond any random within-subject variation in healthy men but we detected no moderation by the FTO genotype. These findings highlight the importance of exploring individual differences in appetite for the prevention and treatment of obesity. This trial was registered at clinicaltrials.gov as NCT03771690.
Identifiants
pubmed: 31132105
pii: S0022-3166(22)16675-7
doi: 10.1093/jn/nxz062
pmc: PMC6602891
doi:
Substances chimiques
Ghrelin
0
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
EC 1.14.11.33
FTO protein, human
EC 1.14.11.33
Banques de données
ClinicalTrials.gov
['NCT03771690']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1159-1169Informations de copyright
Copyright © American Society for Nutrition 2019.
Références
Int J Obes Relat Metab Disord. 2000 Jan;24(1):38-48
pubmed: 10702749
Biochem Biophys Res Commun. 2000 Dec 29;279(3):909-13
pubmed: 11162448
J Am Soc Nephrol. 2002 Nov;13(11):2748-52
pubmed: 12397045
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
J Clin Endocrinol Metab. 2005 Feb;90(2):1068-71
pubmed: 15522935
J Appl Physiol (1985). 2007 Jun;102(6):2165-71
pubmed: 17347386
Science. 2007 May 11;316(5826):889-94
pubmed: 17434869
Br J Nutr. 2007 Jul;98(1):17-25
pubmed: 17524176
Br J Nutr. 2009 Apr;101(7):1094-102
pubmed: 18680633
Am J Physiol Regul Integr Comp Physiol. 2009 Jan;296(1):R29-35
pubmed: 18987287
Gastroenterology. 2009 Jun;136(7):2115-26
pubmed: 19233179
Pharmacol Ther. 2009 Oct;124(1):44-56
pubmed: 19560488
Stat Methods Med Res. 2011 Dec;20(6):657-66
pubmed: 20739334
Aliment Pharmacol Ther. 2011 Apr;33(8):880-94
pubmed: 21342212
Am J Clin Nutr. 2011 Sep;94(3):717-25
pubmed: 21795439
Appetite. 2012 Oct;59(2):228-33
pubmed: 22369956
Am Stat. 2012 Jan 24;65(4):274-282
pubmed: 23606752
Br J Sports Med. 2014 Oct;48(20):1472-6
pubmed: 23666018
J Clin Invest. 2013 Aug;123(8):3539-51
pubmed: 23867619
Appetite. 2014 Oct;81:116-22
pubmed: 24953196
J Appl Physiol (1985). 2015 Jun 15;118(12):1450-9
pubmed: 25663672
Exp Physiol. 2015 Jun;100(6):577-88
pubmed: 25823596
Stat Med. 2016 Mar 30;35(7):966-77
pubmed: 26415869
Appetite. 2017 Jan 1;108:375-382
pubmed: 27984188
Sports Med. 2017 Aug;47(8):1501-1513
pubmed: 28097487
J Nutr. 2017 May;147(5):727-745
pubmed: 28356427
Med Sci Sports Exerc. 2017 Jun;49(6):1219-1228
pubmed: 28511192
Nutrients. 2017 Jun 14;9(6):null
pubmed: 28613252
Diabetologia. 2018 Feb;61(2):496-497
pubmed: 29143064
Med Sci Sports Exerc. 2018 Apr;50(4):758-768
pubmed: 29240652
Am J Clin Nutr. 2018 Feb 1;107(2):145-154
pubmed: 29529147
Obes Rev. 2018 Jul;19(7):960-975
pubmed: 29701297
BMJ. 2018 Nov 5;363:k3750
pubmed: 30560792
J Appl Physiol. 1974 Aug;37(2):247-8
pubmed: 4850854
Br J Nutr. 1978 Nov;40(3):497-504
pubmed: 718832